ask="N/A"
ask_size="N/A"
average_daily_volume="38720"
bid="11.00"
bid_size="300"
book_value="5.24"
change="-1.13"
change_from_200_day_moving_average="-6.10"
change_from_50_day_moving_average="-3.08"
change_from_52_week_high="-13.44"
change_From_52_week_low="2.90"
change_in_percent="-8.04%"
close="12.92"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.80"
ebitda="-32.35M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.62"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="7128000"
high="13.86"
high_52_weeks="26.36"
last_trade_date="3/14/2017"
last_trade_price="12.92"
last_trade_size="400"
last_trade_time="4:00pm"
low="12.40"
low_52_weeks="10.02"
market_capitalization="216.89M"
moving_average_200_day="19.02"
moving_average_50_day="16.00"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="13.79"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-32.07%"
percent_change_from_50_day_moving_average="-19.25%"
percent_change_from_52_week_high="-50.99%"
percent_change_from_52_week_low="+28.94%"
previous_close="14.05"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="28.09"
price_per_book="2.68"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16787000"
short_ratio="9.96"
stock_exchange="NGM"
symbol="PTGX"
volume="50429"
weeks_range_52="10.02 - 26.36"
